China Nuokang Bio-Pharmaceutical Inc. Appoints Lazard and Houlihan Lokey as Independent Financial Advisors to Evaluate "Going Private" Proposal

Published: Jun 04, 2012

BEIJING, June 4, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that the independent committee of the Company's board of directors (the "Independent Committee") has appointed Lazard and Houlihan Lokey as its independent financial advisors.

Back to news